Myasthenia Gravis Flashcards
Myasthenia Gravis (MG)
An autoimmune disease
-acquired
Characterized by fluctuating weakness of certain muscle groups
Course of the disease variable:
- Short-term remission
- Stabilization
- Severe, progressive
MG: Etiology
Risk Factors:
- Age: 10-65
- Gender: women
Etiology:
-Same as every other autoimmune disease!
Pathogenesis
Antibodies attack ACh receptors
-AKA “anti-ACh antibodies”
Decrease in ACh receptor sites at the NMJ
This prevents ACh molecules from attaching and stimulating muscle contraction
Diminished nerve impulse to the muscle
Clinical Manifestations
Fluctuating weakness of skeletal muscle
Strength comes back after resting
Muscle involved:
- Eyes/eyelids
- Facial
- Speaking
- Breathing
Myasthenic Crisis
Acute exacerbation of muscle weakness Triggered by Stressor:
- Infection
- surgery
- emotional distress
- pregnancy/menses’
- inadequate pharmacotherapy or other drugs
Major complication:
-Breathing muscle weakness
MG: Pharm
- Immunosuppressants
- Cholinesterase Inhibitors
How do Cholinesterase inhibiters work?
- Prevent inactivation of ACh by cholinesterase
- Intensify the effect of ACh release from the motor neurons: Increases muscle strength
Are cholinesterase inhibitors a cure or symptomatic relief?
-Only symptoms
Multiple administration routes
Neostigmine (Prostigmin)
Class:
-Cholinesterase Inhibitor (anticholinesterase)
Indication:
-MG
MOA:
-In therapeutic doses, this drug affects both muscarinic and nicotinic receptors
CNS (where are receptors located)
Glands, Adrenal, sweat, blood vessels, skeletal muscles
Cholinergic VS Anticholinergics (EXAM)
CHOLINERGICS GI Tract: Inc motility Mouth: Inc secretions Bladder: urinary urgency Heart: Brady Lungs: Bronchial Constrict Eyes: Miosis (constrict)
ANTICHOLINERGICS GI Tract: Dec motility Mouth: Dry mouth Bladder: Urinary retention Heart: Tachycardia Lungs Bronchodilation Eyes: Mydriasis (dilation)
Neostigmine: AE
Muscarinic:
- Inc secretions, Motility
- Urinary Urgency
- Bradycardia
- Bronchiole Constriction
- Miosis, near-sightedness
Neuromuscular (Nicotinic)
-Therapeutic doses: Increased muscle contraction
-Toxic doses: reduced contraction
TOXICITY: Cholinergic Crisis
Cholinergic Crisis
Extreme muscle weakness or paralysis
S/S of excessive muscarinic stimulation
Treatment:
- Mechanical ventilation
- Antidote for muscarinic Sx: ATROPINE
What should the patient wear at all times?
-Med alert bracelet
MG crisis VS Cholinergic crisis
MG Crisis:
- Not enough stimulation of ACh
- Muscles are not stimulated and weak (leading to respiratory failure)
Cholinergic crisis:
- Too much ACh or Neostigmine
- Overstimulation of muscles and muscles are worn out. (leading to respiratory failure)
How can we tell the difference in a patient?
Client presents with respiratory insufficiency, extreme muscle weakness
Give Edrophonium
- a short acting cholinesterase inhibitor
- Increases ACh temporarily
If they are in MG crisis, they will improve because there is an increase in ACh
If they are in a cholinergic crisis, they will worsen because they already have too much ACh